Table 3.
Primary end point: safety | All adverse events will be recorded throughout the study period. All serious and unexpected adverse events will be reported to the IDMC. |
Secondary end points: efficacy | Change of ISNCSCI total motor scores at the 52 nd week from the baseline. |
Sequential transition of ISNCSCI motor scores. | |
Sequential transition of AIS classification. | |
Sequential transition of ISNCSCI sensory scores. | |
Sequential transition of modified Frankel classification. | |
Sequential transition of the zone of partial preservation. | |
Sequential transition of PainDETECT scores (Japanese version). | |
Sequential transition of the Neuropathic Pain Symptom Inventory (Japanese version). | |
Sequential transition of the modified Ashworth scale. | |
Sequential transition of Spinal Cord Independence Measure version III (Japanese version). | |
Another end point: efficacy | Change of ISNCSCI motor scores at the 24th week from the baseline. |
Abbreviations: IDMC, independent data monitoring committee; ISNCSCI, International Standards for Neurological Classification of Spinal Cord Injury; AIS, American Spinal Cord Injury Association Impairment Scale.